Allyson Zella Prater
Medical · Pittsburgh, PANPI 1265490742
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 1,718 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,718 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Novartis$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Biogen$2K
- AstraZeneca$1K
- Lundbeck LLC$1K
- plus $20K from 54 others
What the payments were for
- Consulting fees$4751%
- Speaking & faculty fees$1,1314%
- Travel & lodging$4691%
- Food & beverage$29,40393%
- Education$2571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,735 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 24 | $346,348 |
| Kesimpta PenOfatumumab | 26 | $244,017 |
| AubagioTeriflunomide | 21 | $186,950 |
| MayzentSiponimod | 11 | $144,567 |
| Rebif RebidoseInterferon Beta-1a/Albumin | 13 | $134,518 |
| Nurtec OdtRimegepant Sulfate | 102 | $132,867 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 12 | $94,282 |
| Glatiramer Acetate | 52 | $91,482 |
| CopaxoneGlatiramer Acetate | 12 | $70,964 |
| BotoxOnabotulinumtoxina | 45 | $59,917 |
| AptiomEslicarbazepine Acetate | 32 | $56,929 |
| Aimovig AutoinjectorErenumab-Aooe | 49 | $47,926 |
| Trokendi XrTopiramate | 11 | $41,804 |
| Teriflunomide | 42 | $30,838 |
| Dalfampridine ErDalfampridine | 92 | $28,852 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $80 | $346,34824 claims |
| SanofiAubagio | $1,282 | $186,95021 claims |
| NovartisMayzent | $1,855 | $144,56711 claims |
| PfizerNurtec Odt, Dilantin | $931 | $138,675123 claims |
| AbbVieBotox, Qulipta, Ubrelvy, Namzaric | $3,506 | $128,573117 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $1,793 | $70,96412 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $91 | $56,92932 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $108 | $41,80411 claims |
| UCB, Inc.Neupro | $879 | $28,30516 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $247 | $19,84212 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $83 | $2,39843 claims |
| Upsher-smith Laboratories LLCTopiramate | $70 | $1,746174 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Pittsburgh
- Patrick OffiPittsburgh$63K
- Haley WhitePittsburgh$34K
- Braeden BashPittsburgh$27K
- Caroline O'NeilPittsburgh$25K
- Michael TometskoPittsburgh$16K
- Tori PipakPittsburgh$15K
- Juliette Bender HeinePittsburgh$15K
- Aimee HerringtonPittsburgh$14K
- Sarah AbrahamPittsburgh$14K
- Jacqueline KernaghanSpringfield$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.